Elisabeth Gaudernak

Title: Elisabeth Gaudernak: Innovator in Antiviral Research

Introduction

Elisabeth Gaudernak is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of antiviral research, particularly through her innovative work on dithiocarbamate compounds. Her research focuses on developing agents that can treat or prevent infections caused by RNA viruses.

Latest Patents

Elisabeth holds a patent for "Dithiocarbamate antiviral agents and methods of using same." This invention discloses the use of dithiocarbamate compounds characterized by the structural formula RRNCSH. In this formula, R and R can independently represent straight or branched C-Calkyl groups, or they can form an aliphatic ring with 4 to 6 carbon atoms. The compounds may also be substituted with various functional groups, including OH, NO, NH, COOH, SH, and halogens. This patent aims to prepare agents for treating or preventing infections by RNA viruses that affect the respiratory tract.

Career Highlights

Elisabeth Gaudernak is associated with Avir Green Hills Biotechnology Research Development Trade AG, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of antiviral agents and their applications in medicine.

Collaborations

Elisabeth has collaborated with notable colleagues, including Andreas Grassauer and Ernst Küchler. These partnerships have enhanced her research capabilities and contributed to the success of her projects.

Conclusion

Elisabeth Gaudernak is a trailblazer in the field of antiviral research, with a focus on innovative compounds that can combat RNA viruses. Her contributions through her patent and collaborations highlight her commitment to advancing medical science.